Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.085
-0.055 (-4.82%)
May 18, 2026, 11:06 AM EDT - Market open
Cognition Therapeutics Employees
Cognition Therapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 14 or -50.00% compared to the previous year.
Employees
14
Change (1Y)
-14
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,398,357
Market Cap
96.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | -14 | -50.00% | 14 | 0 |
| Dec 31, 2024 | 28 | 0 | - | 25 | 3 |
| Dec 31, 2023 | 28 | 3 | 12.00% | 25 | 3 |
| Dec 31, 2022 | 25 | 4 | 19.05% | 22 | 3 |
| Dec 31, 2021 | 21 | 1 | 5.00% | 19 | 2 |
| Sep 30, 2021 | 18 | -2 | -10.00% | 15 | 3 |
| Jun 30, 2021 | 22 | - | - | 18 | 4 |
| Mar 31, 2021 | 22 | - | - | 20 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 124 |
| Cibus | 118 |
| Inovio Pharmaceuticals | 112 |
| PepGen | 56 |
| Vivani Medical | 42 |
| Biomea Fusion | 41 |
| Aardvark Therapeutics | 40 |
| Oncolytics Biotech | 29 |
CGTX News
- 4 days ago - Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies - GlobeNewsWire
- 10 days ago - Cognition Therapeutics reports Q1 EPS (5c), consensus (7c) - TheFly
- 10 days ago - Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Cognition Therapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 5 weeks ago - Cognition Therapeutics to Present at Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Cognition Therapeutics CEO Issues Letter to Shareholders - GlobeNewsWire
- 7 weeks ago - Cognition Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update - GlobeNewsWire